<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/D5337A10-AC8A-402A-8164-C5F9CC6B0140"><gtr:id>D5337A10-AC8A-402A-8164-C5F9CC6B0140</gtr:id><gtr:name>Queen Mary, University of London</gtr:name><gtr:address><gtr:line1>Mile End Road</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>E1 4NS</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/DC934AED-9432-4385-AEAF-006EA2369001"><gtr:id>DC934AED-9432-4385-AEAF-006EA2369001</gtr:id><gtr:name>University of Huddersfield</gtr:name><gtr:address><gtr:line1>Queensgate</gtr:line1><gtr:line4>Huddersfield</gtr:line4><gtr:line5>West Yorkshire</gtr:line5><gtr:postCode>HD1 3DH</gtr:postCode><gtr:region>Yorkshire and The Humber</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/DA9C8AA9-EA46-47C9-A102-04313236F9D5"><gtr:id>DA9C8AA9-EA46-47C9-A102-04313236F9D5</gtr:id><gtr:name>Protexin</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3B4CD670-EFA7-4A29-8208-6EE0C7AE6545"><gtr:id>3B4CD670-EFA7-4A29-8208-6EE0C7AE6545</gtr:id><gtr:name>Shire Pharmaceuticals</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/90EC5CA8-B727-4B0B-BC88-EE78F4FCA198"><gtr:id>90EC5CA8-B727-4B0B-BC88-EE78F4FCA198</gtr:id><gtr:name>Tioga Pharmaceuticals</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/20E66A18-4A43-4DD5-BA98-5320F6EC9269"><gtr:id>20E66A18-4A43-4DD5-BA98-5320F6EC9269</gtr:id><gtr:name>GlaxoSmithKline (GSK)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/F5914C2A-6AE8-4A26-ACA8-99C3D6D87514"><gtr:id>F5914C2A-6AE8-4A26-ACA8-99C3D6D87514</gtr:id><gtr:name>University of Melbourne</gtr:name><gtr:address><gtr:line1>University of Melbourne</gtr:line1><gtr:line2>Melbourne Research Office</gtr:line2><gtr:line3>Parkville</gtr:line3><gtr:line4>Melbourne</gtr:line4><gtr:line5>Victoria</gtr:line5><gtr:postCode>3010</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Australia</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/D5337A10-AC8A-402A-8164-C5F9CC6B0140"><gtr:id>D5337A10-AC8A-402A-8164-C5F9CC6B0140</gtr:id><gtr:name>Queen Mary, University of London</gtr:name><gtr:department>Blizard Institute of Cell and Molecular</gtr:department><gtr:address><gtr:line1>Mile End Road</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>E1 4NS</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D5337A10-AC8A-402A-8164-C5F9CC6B0140"><gtr:id>D5337A10-AC8A-402A-8164-C5F9CC6B0140</gtr:id><gtr:name>Queen Mary, University of London</gtr:name><gtr:address><gtr:line1>Mile End Road</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>E1 4NS</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/DC934AED-9432-4385-AEAF-006EA2369001"><gtr:id>DC934AED-9432-4385-AEAF-006EA2369001</gtr:id><gtr:name>University of Huddersfield</gtr:name><gtr:address><gtr:line1>Queensgate</gtr:line1><gtr:line4>Huddersfield</gtr:line4><gtr:line5>West Yorkshire</gtr:line5><gtr:postCode>HD1 3DH</gtr:postCode><gtr:region>Yorkshire and The Humber</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/DA9C8AA9-EA46-47C9-A102-04313236F9D5"><gtr:id>DA9C8AA9-EA46-47C9-A102-04313236F9D5</gtr:id><gtr:name>Protexin</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3B4CD670-EFA7-4A29-8208-6EE0C7AE6545"><gtr:id>3B4CD670-EFA7-4A29-8208-6EE0C7AE6545</gtr:id><gtr:name>Shire Pharmaceuticals</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/90EC5CA8-B727-4B0B-BC88-EE78F4FCA198"><gtr:id>90EC5CA8-B727-4B0B-BC88-EE78F4FCA198</gtr:id><gtr:name>Tioga Pharmaceuticals</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/20E66A18-4A43-4DD5-BA98-5320F6EC9269"><gtr:id>20E66A18-4A43-4DD5-BA98-5320F6EC9269</gtr:id><gtr:name>GlaxoSmithKline (GSK)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/F5914C2A-6AE8-4A26-ACA8-99C3D6D87514"><gtr:id>F5914C2A-6AE8-4A26-ACA8-99C3D6D87514</gtr:id><gtr:name>University of Melbourne</gtr:name><gtr:address><gtr:line1>University of Melbourne</gtr:line1><gtr:line2>Melbourne Research Office</gtr:line2><gtr:line3>Parkville</gtr:line3><gtr:line4>Melbourne</gtr:line4><gtr:line5>Victoria</gtr:line5><gtr:postCode>3010</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Australia</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/D686AD81-9486-4B49-BC24-C6747674CF66"><gtr:id>D686AD81-9486-4B49-BC24-C6747674CF66</gtr:id><gtr:firstName>Gareth John</gtr:firstName><gtr:surname>Sanger</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0900805"><gtr:id>8D51970B-F212-4F32-B9A0-7B13A8705652</gtr:id><gtr:title>Proposal to develop a gastrointestinal (GI) neuropharmacology platform within the Neurogastroenterology Group (NGG)</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0900805</gtr:grantReference><gtr:abstractText>Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.</gtr:abstractText><gtr:fund><gtr:end>2011-04-19</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2009-04-20</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>212485</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Queen Mary University of London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Barts and The London School of Medicine and Dentistry</gtr:department><gtr:description>Evaluation of human gastrointestinal activity of sera from Chagas patients</gtr:description><gtr:id>703FD8A2-D7C7-4B2B-ACA1-85F4F24B08E0</gtr:id><gtr:impact>For the first time we have shown an inhibitory activity on the muscle of naive humab colon which is independent of neuronal activity and not carried by the antibodies within the blood sera. Experiments are ongoing to isolate the mechanism of action. Abstracts have been prepared for submission.</gtr:impact><gtr:outcomeId>Tmp8FAEiXa8-1</gtr:outcomeId><gtr:partnerContribution>Gave access to sera from Chagas' patients</gtr:partnerContribution><gtr:piContribution>The new human tissue lab enabled, for the first time, blood sera to be tested on human isolated colon, looking for changes in muscle and motor nerve functions, indicative of changes in motility.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Protexin</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Identification of enteric bacteria modulating intestinal functions</gtr:description><gtr:id>8A02FE60-953E-4BB6-A07B-DB7B4CCC9248</gtr:id><gtr:impact>Bacteria identified and screened. Too early to report final data.</gtr:impact><gtr:outcomeId>dC42N1ZUbX7-1</gtr:outcomeId><gtr:partnerContribution>Access to profiled bacteria and knowhow</gtr:partnerContribution><gtr:piContribution>Identification of bacteria from human biopsies. Characterisation of the ability of the bacteria to survive ingestion into the gut and be retained for long enough to have activity. About to begin functional testing.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Shire Pharmaceuticals</gtr:collaboratingOrganisation><gtr:country>Ireland, Republic of</gtr:country><gtr:description>Evaluation of new drug targets for gastrointestinal disease</gtr:description><gtr:id>AE5EF3FF-8170-4DCC-920B-8FB85FB12B1B</gtr:id><gtr:impact>Recently started</gtr:impact><gtr:outcomeId>XRYck3RvN8f-1</gtr:outcomeId><gtr:partnerContribution>Research collaboration</gtr:partnerContribution><gtr:piContribution>Recently started. Focus is on the use of human tissues to measure function</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Huddersfield</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>School of Applied Sciences Huddersfield</gtr:department><gtr:description>Anti-emetic activity of erythromycin</gtr:description><gtr:id>EEC27FDF-F5F7-48D4-B919-5251552855A9</gtr:id><gtr:impact>Data has been prepared as a manuscript which will be submitted for publication before end-2010. Additional data (funded directly to Huddersfield by GSK, but under my direction) evaluated a proprietry compound.</gtr:impact><gtr:outcomeId>DBTECwJbpsS-1</gtr:outcomeId><gtr:partnerContribution>The collaborator has access to an animal model of vomiting (currently unique within the UK). My contribution was to direct the research which evaluated the dose-dependent pro- and anti-emetic activities of motilin receptor agonists. This is the first time anti-emetic activity has been demonstrated, using low doses of compound. Overall, such data ties in well with our current interests in motilin and other gastrointestinal hormones.</gtr:partnerContribution><gtr:piContribution>Direction of the research</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Melbourne</gtr:collaboratingOrganisation><gtr:country>Australia, Commonwealth of</gtr:country><gtr:description>Research into ghrelin</gtr:description><gtr:id>61A2DEDD-0052-4975-8B7F-F2D322BEA857</gtr:id><gtr:impact>One peer reviewed publication (original data)
One peer-reviewed review
One invitation to write a book chapter (completed)</gtr:impact><gtr:outcomeId>56b1fc247d04b6.42508720-1</gtr:outcomeId><gtr:partnerContribution>Provided intellectual input and laboratory facilities</gtr:partnerContribution><gtr:piContribution>Research Fellow worked in collaborator laboratory for a short while</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Tioga Pharmaceuticals</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Evaluation of kappa opioid receptor agonists in human and mouse colon</gtr:description><gtr:id>0A2DEDA9-BACD-4456-9646-06753835A57D</gtr:id><gtr:impact>Publication of manuscript</gtr:impact><gtr:outcomeId>Lcbi9GfggMR-1</gtr:outcomeId><gtr:partnerContribution>Supplied data to enable proper design + funding</gtr:partnerContribution><gtr:piContribution>Conducted and designed research</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>GlaxoSmithKline (GSK)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Respiratory Centers for Excellence for Drug Discovery CEDD GSK</gtr:department><gtr:description>Exploration of human gastrointestinal functions of motilin</gtr:description><gtr:id>9F80BBA9-7252-4359-A7B9-F0CF0BF65F15</gtr:id><gtr:impact>Provision of a new lab to work on human gastrointestinal tissues (focus on function &amp;amp; also immunohistochemistry) removed normally at surgery with informed consent.

Data demonstrating the ability of motilin receptor agonists to facilitate cholinergic (&amp;amp; to a lesser extent, nitrergic) function in human isolated gastrointestinal tissues (esophagus, gastric fundus, gastric antrum, but not terminal ileum, right and left colon). Provides useful data for industry + demonstrated translational value of these human models. Published as abstracts.

Provision of Regulatory Documents on GSK propietry compounds, to allow filing for clinical trials.

Data demonstrating the ability of a 5-HT4 receptor agonist (prucalopride) and a cholinesterase inhibitor (donepezil, used to treat Alzheimer's) to facilitate motor nerve functions (cholinergic and nitrergic (5-HT4 only)) in human isolated colon, thereby demonstrating the translational value of this model. Abstracts published.</gtr:impact><gtr:outcomeId>fyjbswELrzc-1</gtr:outcomeId><gtr:partnerContribution>Access to restricted compounds</gtr:partnerContribution><gtr:piContribution>Provision of a new lab to work on human gastrointestinal tissues removed normally at surgery with informed consent.

Development of method of measuring motor nerve function in a range of different human isolated gastrointestinal tissues (esophagus, gastric fundus, gastric antrum, terminal ileum, right and left colon) &amp;amp; demonstration (for the first time) of activity in these models by motilin and motilin receptor agonists. Published as abstracts.

Development of immunohistochemistry methods for staining motilin receptors in human gastrointestinal tissues.

Measurement of effects of alternative ways of stimulating human gastrointestinal motor nerve functions (5-HT4, AChE inhibition). Abstracts published.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Blog</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>063565D8-09C3-4DD8-BF16-08849DC1C6B5</gtr:id><gtr:impact>Blog

One blog led to another</gtr:impact><gtr:outcomeId>hCbsTgCXp6q</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Paper Presentation</gtr:presentationType><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:url>http://?	Why not use human material to study human biology and diseases?  NC3Rs blog: http://blog.nc3rs.org.uk (16.04.13)</gtr:url><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Blog</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>23C0ABC6-94EA-4421-AAEF-9D31FF907518</gtr:id><gtr:impact>Blog to members of the public

One blog led to another</gtr:impact><gtr:outcomeId>sAp2iG8MuG2</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Paper Presentation</gtr:presentationType><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:url>http://?	Cut down on animal testing by building a human tissue lab. Published on The Conversation: http://theconversation.com/cut-down-on-animal-testing-by-building-a-human-tissue-lab-15525 (28.07.13).</gtr:url><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Blog</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>553743E2-61F2-4438-8E31-3E36781CA3E5</gtr:id><gtr:impact>Blog

Influence policy</gtr:impact><gtr:outcomeId>TTE9tAgpTuZ</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Paper Presentation</gtr:presentationType><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:url>http://   ?	HIS: Replacing animals in research (video coinciding with release of Home Office animal use statistics: 17.07.13): http://www.hsi.org/world/united_kingdom/news/news/2013/07/home_office_stats_071613.html.</gtr:url><gtr:year>2013</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>32231</gtr:amountPounds><gtr:country>Global</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>Academic Discovery Performance Unit</gtr:department><gtr:description>GlaxoSmithKline</gtr:description><gtr:end>2013-01-02</gtr:end><gtr:fundingOrg>GlaxoSmithKline (GSK)</gtr:fundingOrg><gtr:id>16B5694C-D699-4087-BC3B-33FB5F1C7100</gtr:id><gtr:outcomeId>ZDKmbZxgjMW</gtr:outcomeId><gtr:sector>Private</gtr:sector><gtr:start>2012-02-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>50000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>USD</gtr:currCode><gtr:currCountryCode>Ecuador</gtr:currCountryCode><gtr:currLang>es_EC</gtr:currLang><gtr:description>Exploratory Research</gtr:description><gtr:end>2014-08-02</gtr:end><gtr:fundingOrg>Tioga Ltd, Derby</gtr:fundingOrg><gtr:id>4CF337C2-24B1-4B08-86A7-4751D5F80A8D</gtr:id><gtr:outcomeId>54536a4bc554f1.14262921</gtr:outcomeId><gtr:sector>Private</gtr:sector><gtr:start>2013-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>720836</gtr:amountPounds><gtr:country>Global</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Research Collaboration</gtr:description><gtr:end>2017-11-02</gtr:end><gtr:fundingOrg>Takeda Pharmaceutical Company</gtr:fundingOrg><gtr:id>68F9179D-7515-4C98-B0DD-2261C428EAB2</gtr:id><gtr:outcomeId>56b1f143703c08.54172002</gtr:outcomeId><gtr:sector>Private</gtr:sector><gtr:start>2014-12-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>77250</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>AgeUK</gtr:description><gtr:end>2016-01-02</gtr:end><gtr:fundingOrg>Age UK</gtr:fundingOrg><gtr:id>376A0D30-F213-4E98-AC88-605F06163E84</gtr:id><gtr:outcomeId>JLkcxkA25xs</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2013-02-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>128789</gtr:amountPounds><gtr:country>Ireland, Republic of</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Exploratory Research</gtr:description><gtr:end>2012-06-02</gtr:end><gtr:fundingOrg>Shire Pharmaceuticals</gtr:fundingOrg><gtr:id>BAB634A2-73B0-4E88-9573-0BAA9D1A3C7C</gtr:id><gtr:outcomeId>54536ac6ebe3e0.56338794</gtr:outcomeId><gtr:sector>Private</gtr:sector><gtr:start>2011-07-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>9000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Research Collaboration</gtr:description><gtr:end>2013-07-02</gtr:end><gtr:fundingOrg>Protexin</gtr:fundingOrg><gtr:id>62003DDA-8262-45A0-A56D-3CD5D6E3EDB3</gtr:id><gtr:outcomeId>56b1f3d7697547.74085399</gtr:outcomeId><gtr:sector>Private</gtr:sector><gtr:start>2013-03-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>102126</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>BBSRC</gtr:description><gtr:end>2018-08-02</gtr:end><gtr:fundingOrg>Biotechnology and Biological Sciences Research Council (BBSRC)</gtr:fundingOrg><gtr:id>80E17AAC-C9FD-4078-9B31-AC22CB18B2B5</gtr:id><gtr:outcomeId>545369bc3568e5.62383571</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2014-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>220464</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Research Collaboration</gtr:description><gtr:end>2013-04-02</gtr:end><gtr:fundingOrg>Protexin</gtr:fundingOrg><gtr:id>87E278F4-9E59-41FE-846B-FE2D7C37779C</gtr:id><gtr:outcomeId>56b1f4aa1940c6.34418559</gtr:outcomeId><gtr:sector>Private</gtr:sector><gtr:start>2011-05-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>215667</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Research Grant</gtr:description><gtr:end>2018-01-02</gtr:end><gtr:fundingOrg>The Dunhill Medical Trust</gtr:fundingOrg><gtr:id>021A8382-779C-406D-B6B6-BBB8E91FEFDC</gtr:id><gtr:outcomeId>56b1f32d883812.97229765</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2015-02-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>120626</gtr:amountPounds><gtr:country>Global</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Research Collaboration</gtr:description><gtr:end>2011-08-02</gtr:end><gtr:fundingOrg>GlaxoSmithKline (GSK)</gtr:fundingOrg><gtr:id>98326348-AD78-4127-9D87-2FE4AFA58C34</gtr:id><gtr:outcomeId>56b1f65fce60a8.01379697</gtr:outcomeId><gtr:sector>Private</gtr:sector><gtr:start>2009-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1000</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>UEGF Travel Award for PostDoc</gtr:description><gtr:end>2011-10-02</gtr:end><gtr:fundingOrg>United European Gastroenterology</gtr:fundingOrg><gtr:id>97B0771C-C4B7-474E-B266-CE320302EAC1</gtr:id><gtr:outcomeId>CwvTFNpozn90</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2011-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>45140</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Bowel and Cancer Research</gtr:description><gtr:end>2013-07-02</gtr:end><gtr:fundingOrg>Bowel Cancer UK</gtr:fundingOrg><gtr:id>4FDDF39F-4D21-4E58-A149-C581E91E0EB6</gtr:id><gtr:outcomeId>o2j9HJWN81i</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2012-08-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>24000</gtr:amountPounds><gtr:country>Japan</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Research Collaboration</gtr:description><gtr:end>2014-10-02</gtr:end><gtr:fundingOrg>RaQualia Pharma Inc.</gtr:fundingOrg><gtr:id>079245AF-3A35-4002-8592-5DDC7710986B</gtr:id><gtr:outcomeId>56b1f261ab2167.04299721</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2014-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>32000</gtr:amountPounds><gtr:country>Unknown</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Contract Research</gtr:description><gtr:end>2013-12-02</gtr:end><gtr:fundingOrg>Transpharmation</gtr:fundingOrg><gtr:id>B7EDC4E6-4F1F-4F58-AA3C-F9BF1105FAF0</gtr:id><gtr:outcomeId>r2k6ewyBdyc</gtr:outcomeId><gtr:sector>Private</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Wellcome Trust Peer Review College</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>C73F521B-6EDB-45AE-ADB9-47412EECA588</gtr:id><gtr:outcomeId>54536c27a80508.32474348</gtr:outcomeId><gtr:type>Membership of a guidance committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Editor of Section of IUPHAR database defining the motilin receptor</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>55C2B9F9-0AD4-4A89-B7DD-2DE3FE60498C</gtr:id><gtr:outcomeId>56b1ff19bb0494.20751284</gtr:outcomeId><gtr:type>Membership of a guideline committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Membership of advisory committee</gtr:description><gtr:geographicReach>Europe</gtr:geographicReach><gtr:id>DB897EB9-BB14-413A-A1FD-02BE38A2E68E</gtr:id><gtr:outcomeId>58b037a40970d6.63454297</gtr:outcomeId><gtr:type>Participation in a advisory committee</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>We collect human gastrointestinal tissues removed as a normal part of surgery after informed consent. Motor nerve function is assessed by electrically stimulating the nerves &amp;amp; then dissecting out the nerve phenotypes using pharmacological tools. Tissues are usually from patients with cancer, obesity or inflammatory bowel disease. Some of our methods are not novel but are rarely performed in the UK. Other methods (eg use of stomach) are novel. In each region of the gut translational value is assessed by determining the effects of clinical standards, known to affect gastrointestinal function. In this way, we provide a unique facility (within the UK) - the use of human isolated gastrointestinal tissues to measure function and to compare and validate that function by comparison with clinical standards. Other laboratories do not offer the latter, simply undertaking contract research.</gtr:description><gtr:id>64FC3066-134C-4A47-800A-E1A1616C7DC6</gtr:id><gtr:impact>Our laboratory is attracting considerable interest from industry. Three different contracts for research (apart from GSK) are currently being negotiated.

We have joined a human tissue consortium, offering assays for hire. We are one of the rare labs which offer native tissues and not cell biology.

We have trained one other UK lab in techniques</gtr:impact><gtr:outcomeId>sgwV2jikjAZ</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Human isolated gastrointestinal functions with translational value</gtr:title><gtr:type>Model of mechanisms or symptoms - in vitro</gtr:type><gtr:yearFirstProvided>2012</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>8D867733-52B2-43CD-AF84-9797B781F5E2</gtr:id><gtr:title>Regionally dependent neuromuscular functions of motilin and 5-HT4 receptors in human isolated esophageal body and gastric fundus.</gtr:title><gtr:parentPublicationTitle>Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/41938236707bb9c8bdcdb26d0d5b3144"><gtr:id>41938236707bb9c8bdcdb26d0d5b3144</gtr:id><gtr:otherNames>Broad J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1350-1925</gtr:issn><gtr:outcomeId>56b88011998104.26448166</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E9495BD2-4E03-473C-974D-463DCFB406F8</gtr:id><gtr:title>Evidence for Reduced Visceral Nociceptors Activation With Age During Appendicitis</gtr:title><gtr:parentPublicationTitle>GASTROENTEROLOGY</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/63cc093cca0ba41838b2eb727c7e57ab"><gtr:id>63cc093cca0ba41838b2eb727c7e57ab</gtr:id><gtr:otherNames>Cibert-Goton Vincent</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0016-5085</gtr:issn><gtr:outcomeId>56b203074bc129.05313801</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>12E4AFE1-80FA-49AC-ABD0-A5FF0C3CDBDB</gtr:id><gtr:title>PWE-051 Studies of the psychophysiological markers and the brain processing of nausea in healthy humans using a novel virtual reality video</gtr:title><gtr:parentPublicationTitle>Gut</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/800cb12efd41f1d746aaf53a9fa1d2f9"><gtr:id>800cb12efd41f1d746aaf53a9fa1d2f9</gtr:id><gtr:otherNames>Ng K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0017-5749</gtr:issn><gtr:outcomeId>56b878f7098784.16444616</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A9D05606-08BA-483E-BF40-8AA885D40FB9</gtr:id><gtr:title>Drugs acting at 5-HT4 , D2 , motilin, and ghrelin receptors differ markedly in how they affect neuromuscular functions in human isolated stomach.</gtr:title><gtr:parentPublicationTitle>Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/41938236707bb9c8bdcdb26d0d5b3144"><gtr:id>41938236707bb9c8bdcdb26d0d5b3144</gtr:id><gtr:otherNames>Broad J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1350-1925</gtr:issn><gtr:outcomeId>56b878f45a9a40.55615244</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>14F88090-D255-4F95-B23E-51CE48646AF2</gtr:id><gtr:title>Identifying Human Biomarkers of Nausea for Refining Animal Studies on Emesis</gtr:title><gtr:parentPublicationTitle>GASTROENTEROLOGY</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c4d99a35adcab60f29d6bc3b834ecfd1"><gtr:id>c4d99a35adcab60f29d6bc3b834ecfd1</gtr:id><gtr:otherNames>Ng Kee S.</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0016-5085</gtr:issn><gtr:outcomeId>56b87cfa5ceb60.18542689</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E4979639-F574-47A0-822C-BD64A7E5AC30</gtr:id><gtr:title>The antibiotic azithromycin is a motilin receptor agonist in human stomach: comparison with erythromycin.</gtr:title><gtr:parentPublicationTitle>British journal of pharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/41938236707bb9c8bdcdb26d0d5b3144"><gtr:id>41938236707bb9c8bdcdb26d0d5b3144</gtr:id><gtr:otherNames>Broad J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0007-1188</gtr:issn><gtr:outcomeId>C7ZtgBFp3wT</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3586602C-8C15-4CB7-87F1-AEACC899CE3F</gtr:id><gtr:title>PWE-003 Vasopressin contracts human isolated stomach muscle: possible role in nausea?</gtr:title><gtr:parentPublicationTitle>Gut</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/41938236707bb9c8bdcdb26d0d5b3144"><gtr:id>41938236707bb9c8bdcdb26d0d5b3144</gtr:id><gtr:otherNames>Broad J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0017-5749</gtr:issn><gtr:outcomeId>56b86fbab84381.38662525</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DFA1A489-AC95-4B0E-A3AD-A67EDE550A15</gtr:id><gtr:title>Studies of the Psychophysiological Markers and the Brain Processing of Nausea in Healthy Humans Using a Novel Virtual Reality Video</gtr:title><gtr:parentPublicationTitle>GASTROENTEROLOGY</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c4d99a35adcab60f29d6bc3b834ecfd1"><gtr:id>c4d99a35adcab60f29d6bc3b834ecfd1</gtr:id><gtr:otherNames>Ng Kee S.</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0016-5085</gtr:issn><gtr:outcomeId>56b87f4c4095b9.92152807</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2E7CA0DC-7F40-4BE1-A2EA-9B90C0EEAF72</gtr:id><gtr:title>Gender- and regionally-specific decline in colonic neuromuscular activity with advanced age</gtr:title><gtr:parentPublicationTitle>BRITISH JOURNAL OF SURGERY</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8ac228f9a31a78ec2dffdd73de171685"><gtr:id>8ac228f9a31a78ec2dffdd73de171685</gtr:id><gtr:otherNames>Kung V. W. S.</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0007-1323</gtr:issn><gtr:outcomeId>56b203b87e4513.03410405</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7A46E6FE-AAA4-4645-B92F-4348368DA19F</gtr:id><gtr:title>Psychophysiological markers and the brain processing of nausea in healthy humans using a novel virtual reality video</gtr:title><gtr:parentPublicationTitle>NEUROGASTROENTEROLOGY AND MOTILITY</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ce5c357fb77a4a6e23709e06392128b0"><gtr:id>ce5c357fb77a4a6e23709e06392128b0</gtr:id><gtr:otherNames>Ng K. S.</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1350-1925</gtr:issn><gtr:outcomeId>56b88010728857.48908510</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3C394129-5A3F-4083-A0EB-C9FBBC7C5DDD</gtr:id><gtr:title>Age related changes of neuromuscular functions in the human ascending colon</gtr:title><gtr:parentPublicationTitle>NEUROGASTROENTEROLOGY AND MOTILITY</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0ccd1312ce39f71e2459ca5d28b701bb"><gtr:id>0ccd1312ce39f71e2459ca5d28b701bb</gtr:id><gtr:otherNames>Kung V.</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1350-1925</gtr:issn><gtr:outcomeId>56b204104d8bd6.23325485</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>716DCC1B-D840-4627-B127-8DC9EB6C44BC</gtr:id><gtr:title>Ghrelin and motilin receptors as drug targets for gastrointestinal disorders.</gtr:title><gtr:parentPublicationTitle>Nature reviews. Gastroenterology &amp; hepatology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c426dd925f287db025ad4c7ef65dc6c4"><gtr:id>c426dd925f287db025ad4c7ef65dc6c4</gtr:id><gtr:otherNames>Sanger GJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1759-5045</gtr:issn><gtr:outcomeId>56b86b3756cf50.86794639</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B10C0E1A-F3C8-43B4-8EF4-0AA13357D4CA</gtr:id><gtr:title>Regional- and agonist-dependent facilitation of human neurogastrointestinal functions by motilin receptor agonists.</gtr:title><gtr:parentPublicationTitle>British journal of pharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/41938236707bb9c8bdcdb26d0d5b3144"><gtr:id>41938236707bb9c8bdcdb26d0d5b3144</gtr:id><gtr:otherNames>Broad J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0007-1188</gtr:issn><gtr:outcomeId>pm_14710_20_22537158</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5A732C50-3072-44C5-9E49-BC559BC1A856</gtr:id><gtr:title>Motilin receptor neuropharmacology: revised understanding.</gtr:title><gtr:parentPublicationTitle>Current opinion in pharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c426dd925f287db025ad4c7ef65dc6c4"><gtr:id>c426dd925f287db025ad4c7ef65dc6c4</gtr:id><gtr:otherNames>Sanger GJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1471-4892</gtr:issn><gtr:outcomeId>pm_14710_20_22858405</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>68A8D6CF-8FDB-4921-8D38-1E7C8726EE85</gtr:id><gtr:title>Anti-emetic and emetic effects of erythromycin in Suncus murinus: role of vagal nerve activation, gastric motility stimulation and motilin receptors.</gtr:title><gtr:parentPublicationTitle>European journal of pharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/87c4aa77631911aa05ca95a47ba90907"><gtr:id>87c4aa77631911aa05ca95a47ba90907</gtr:id><gtr:otherNames>Javid FA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0014-2999</gtr:issn><gtr:outcomeId>UTMbgcL81ru</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>87C33F08-2546-43FD-82EE-28075CD211FD</gtr:id><gtr:title>Translational neuropharmacology: the use of human isolated gastrointestinal tissues.</gtr:title><gtr:parentPublicationTitle>British journal of pharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c426dd925f287db025ad4c7ef65dc6c4"><gtr:id>c426dd925f287db025ad4c7ef65dc6c4</gtr:id><gtr:otherNames>Sanger GJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0007-1188</gtr:issn><gtr:outcomeId>pm_14710_20_22946540</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>847A070C-E4F8-4EA3-883D-DCC1A6B6C275</gtr:id><gtr:title>Effects of long course preoperative chemo-radiotherapy on neuromuscular functions of the human rectum ex vivo</gtr:title><gtr:parentPublicationTitle>NEUROGASTROENTEROLOGY AND MOTILITY</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0ccd1312ce39f71e2459ca5d28b701bb"><gtr:id>0ccd1312ce39f71e2459ca5d28b701bb</gtr:id><gtr:otherNames>Kung V.</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1350-1925</gtr:issn><gtr:outcomeId>56b20285c29311.59570400</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>46837743-8CA1-45AA-BCE1-921834CFF7FB</gtr:id><gtr:title>Brain Processing of Visual Motion Induced Nausea in Healthy Humans</gtr:title><gtr:parentPublicationTitle>GASTROENTEROLOGY</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c4d99a35adcab60f29d6bc3b834ecfd1"><gtr:id>c4d99a35adcab60f29d6bc3b834ecfd1</gtr:id><gtr:otherNames>Ng Kee S.</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0016-5085</gtr:issn><gtr:outcomeId>56b880fc7afe60.99727057</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F3BBBA40-EAC8-4F78-8640-36C2E4D443F3</gtr:id><gtr:title>The Concise Guide to PHARMACOLOGY 2013/14: overview.</gtr:title><gtr:parentPublicationTitle>British journal of pharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/22eb2c18ba534f4f36ee595a2e355c9a"><gtr:id>22eb2c18ba534f4f36ee595a2e355c9a</gtr:id><gtr:otherNames>Alexander SP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0007-1188</gtr:issn><gtr:outcomeId>545366de0a9d65.98268037</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7B93ED4F-AD33-4FD9-A582-701229D18C57</gtr:id><gtr:title>Visually induced nausea causes characteristic changes in cerebral, autonomic and endocrine function in humans.</gtr:title><gtr:parentPublicationTitle>The Journal of physiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8cc1950295390eb312c1b44fa69a08cb"><gtr:id>8cc1950295390eb312c1b44fa69a08cb</gtr:id><gtr:otherNames>Farmer AD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0022-3751</gtr:issn><gtr:outcomeId>56b1edfc8ecbe6.92158615</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>46EA55D4-636C-4B0F-A117-A1E6371800F0</gtr:id><gtr:title>The translational value of rodent gastrointestinal functions: a cautionary tale.</gtr:title><gtr:parentPublicationTitle>Trends in pharmacological sciences</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c426dd925f287db025ad4c7ef65dc6c4"><gtr:id>c426dd925f287db025ad4c7ef65dc6c4</gtr:id><gtr:otherNames>Sanger GJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0165-6147</gtr:issn><gtr:outcomeId>pm_14710_20_21531468</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FA1D1C6A-7FD9-496E-A67D-F88A0E2AD1DF</gtr:id><gtr:title>Effects of neo-adjuvant chemotherapy for oesophago-gastric cancer on neuro-muscular gastric function.</gtr:title><gtr:parentPublicationTitle>Molecular biology reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0d4ebb7c3db3e1f143b150ed3484fdca"><gtr:id>0d4ebb7c3db3e1f143b150ed3484fdca</gtr:id><gtr:otherNames>Sung EZ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0301-4851</gtr:issn><gtr:outcomeId>pm_14710_20_22744429</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AB984620-F3D1-4A74-9744-CACC02105A25</gtr:id><gtr:title>GSK962040: a small molecule motilin receptor agonist which increases gastrointestinal motility in conscious dogs.</gtr:title><gtr:parentPublicationTitle>Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5a0cb58e86bac0107fca2ccdb17f6cd4"><gtr:id>5a0cb58e86bac0107fca2ccdb17f6cd4</gtr:id><gtr:otherNames>Leming S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1350-1925</gtr:issn><gtr:outcomeId>pm_14710_20_21895874</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6DF412CA-EAEE-4327-B775-225F48C06D59</gtr:id><gtr:title>Novel insights which may translate into treatments for irritable bowel syndrome.</gtr:title><gtr:parentPublicationTitle>Frontiers in pharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f94bda625673e788f9fd940923052c2d"><gtr:id>f94bda625673e788f9fd940923052c2d</gtr:id><gtr:otherNames>Izzo AA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1663-9812</gtr:issn><gtr:outcomeId>56b880104b6201.87400441</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E8E7C927-6125-47EC-884F-79C9AE80DB1C</gtr:id><gtr:title>A Novel Phenotype of Glycogen Storage Disease Presenting as Gastrointestinal Neuromuscular Disease</gtr:title><gtr:parentPublicationTitle>GASTROENTEROLOGY</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/891adf823085a1fa1113eb7e391d3038"><gtr:id>891adf823085a1fa1113eb7e391d3038</gtr:id><gtr:otherNames>Martin Joanne E.</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0016-5085</gtr:issn><gtr:outcomeId>56b86e4c8269e0.35519548</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A93DC313-9FF9-4E6A-9A7C-67961D3B529A</gtr:id><gtr:title>Human native kappa opioid receptor functions not predicted by recombinant receptors: Implications for drug design.</gtr:title><gtr:parentPublicationTitle>Scientific reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/41938236707bb9c8bdcdb26d0d5b3144"><gtr:id>41938236707bb9c8bdcdb26d0d5b3144</gtr:id><gtr:otherNames>Broad J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2045-2322</gtr:issn><gtr:outcomeId>58b02f805aee88.23227880</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CDFA49C6-58AD-4CDA-A520-AA2FEFB75BCD</gtr:id><gtr:title>Cholinergic interactions between donepezil and prucalopride in human colon: potential to treat severe intestinal dysmotility.</gtr:title><gtr:parentPublicationTitle>British journal of pharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/41938236707bb9c8bdcdb26d0d5b3144"><gtr:id>41938236707bb9c8bdcdb26d0d5b3144</gtr:id><gtr:otherNames>Broad J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0007-1188</gtr:issn><gtr:outcomeId>VA7p2FFZ1XW</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2722B761-28B6-4964-AE75-476FEFE611A2</gtr:id><gtr:title>PTH-043 Characterisation of motor nerve responses to electrical field stimulation in human isolated colon</gtr:title><gtr:parentPublicationTitle>Gut</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/41938236707bb9c8bdcdb26d0d5b3144"><gtr:id>41938236707bb9c8bdcdb26d0d5b3144</gtr:id><gtr:otherNames>Broad J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0017-5749</gtr:issn><gtr:outcomeId>56b87844e70e92.49054963</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3214E408-0DB7-4724-A0C3-787855186D03</gtr:id><gtr:title>RQ-00201894: A motilin receptor agonist causing long-lasting facilitation of human gastric cholinergically-mediated contractions.</gtr:title><gtr:parentPublicationTitle>Journal of pharmacological sciences</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/41938236707bb9c8bdcdb26d0d5b3144"><gtr:id>41938236707bb9c8bdcdb26d0d5b3144</gtr:id><gtr:otherNames>Broad J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1347-8613</gtr:issn><gtr:outcomeId>5a96c521d509d6.13841926</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0900805</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>041997EB-CFD8-493D-B0F8-DFA35451D0BE</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Neurological</gtr:text></gtr:healthCategory><gtr:healthCategory><gtr:id>D81A471F-556F-4570-BF6A-5D197943223C</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Oral and Gastrointestinal</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>25</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>1A41A859-2076-46E6-B80F-CE4E1E8EDC1D</gtr:id><gtr:percentage>25</gtr:percentage><gtr:text>1.5  Resources and infrastructure (underpinning)</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>25</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>8F896112-5A04-4A11-A9F0-2B446D9AAC8A</gtr:id><gtr:percentage>25</gtr:percentage><gtr:text>5.1  Pharmaceuticals</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>